A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells.
Hum Vaccin Immunother
; 11(8): 2038-50, 2015.
Article
en En
| MEDLINE
| ID: mdl-26024409
Palabras clave
APC, antigen presenting cell; B cells; BCR, B cell receptor; CMV, cytomegalovirus; CTL, cytotoxic t lymphocyte; DC, dendritic cell; HCMV, human CMV; KO, knock out; LN, lymph node; MHC, major histocompatibility complex; OVA, avalbumin; PBMC, peripheral blood mononuclear cell; SMIP, Small Molecule Immune Potentiator; TLR, toll like receptor; cross presentation/priming; cytotoxic T cells; dendritic cells; vaccination
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Adyuvantes Inmunológicos
/
Reactividad Cruzada
/
Receptor Toll-Like 2
/
Células Presentadoras de Antígenos
Límite:
Animals
Idioma:
En
Revista:
Hum Vaccin Immunother
Año:
2015
Tipo del documento:
Article
País de afiliación:
Italia